Facebook Twitter Instagram Google
Mon - Sun: 9:00am - 10:00pm
Contact : 0333 305 8486

Botox (Botulinum Toxin) Injection Research

This page contains excerpts from Botulinum Toxin (Botox) research papers with links to the full articles.

Botox (Botulinum Toxin) Injection Research

Article Title: Treating glabellar lines with Botulinum Toxin type A-hemagglutinin complex: A review of the science, the clinical data, and patient satisfaction

Source: U.S. National Institutes of Health’s National Library of Medicine

Publication Date: 2010 Apr 26.

Full Article: Available Here

“More than 80% reported that treatment with onabotulinumtoxinA was beneficial, and 100% of the patients would recommend it”

“OnabotulinumtoxinA was approved in 2002 by the FDA to temporarily improve the appearance of moderate to severe glabellar lines in adult patients aged 18 to 65 years”

 


 

Article Title: Botulinum toxin: Bioweapon & magic drug

Source: U.S. National Institutes of Health’s National Library of Medicine

Publication Date: 2010 Nov; 132(5): 489–503.

Full Article: Available Here

“The new uses for this ‘wonder drug’ are under constant evaluation, including gastrointestinal smooth muscles and skeletal muscle spasm following CNS injury, cosmetic management of wrinkles”

 


 

Article Title: Key Parameters for the Use of AbobotulinumtoxinA in Aesthetics: Onset and Duration

Source: U.S. National Institutes of Health’s National Library of Medicine

Publication Date: XXX

Full Article: XXX

“In general, some patients are aware of an improvement in wrinkles within 1 day of treatment, and return of muscle function generally seems to occur 3 to 6 months after treatment.”

 


 

Article Source: Selection and preference for Botulinum Toxins in the management of photoaging and facial lines: patient and physician considerations

Source: U.S. National Institutes of Health’s National Library of Medicine

Publication Date: 2010 Sep 7

Full Article: Available Here

“In this study it was demonstrated that Botulinum Toxin type A offers not only clinical efficacy but also efficacy in addressing aspects of treatment that are of particular importance to patients – such as their desire to improve their facial appearance, have a smoothness to their facial appearance, not look older than they want, and not look tired, stressed, and angry when this is not how they feel.”